未找到相关数据
A real-world evidence study of everolimus plus endocrine therapy beyond CDK4/6 inhibitors for HR+/HER2-advanced breast cancer
被引：1
作者：
Sanchez-Bayona, Rodrigo
Alva, Manuel
de Sa, Alfonso Lopez
Gilarranz, Yolanda Jerez
de Torre, Ana Sanchez
Tolosa, Pablo
de Luna, Alicia
Lopez-Tarruella, Sara
Lema, Laura
Moreno, Fernando
Echavarria, Isabel
Madariaga, Ainhoa
Benitez, Javier
Herrero, Blanca
Rey, Macarena
Ortega, Justo
Gamez, Salvador
Modrego, Andrea
Lozano, Rocio Martin
Figuero-Perez, Luis
Jimenez, Roberto
Sevilla, Marta Gonzalez
Gonzalez, Irene
Beranek, Marianela Bringas
de Toro, Maria
Massarrah, Tatiana
del Monte-Millan, Maria
Pinardo, Marina
Manso, Luis
Bueno-Muino, Coralia
Garcia-Saenz, Jose Angel
Martin, Miguel
Ciruelos, Eva
机构：
关键词：
D O I：
10.1158/1538-7445.SABCS22-P3-01-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-01-04
引用
收藏
页数：3
相关论文